Decreased SIRT1 deacetylase activity in sporadic inclusion-body myositis muscle fibers

Neurobiology of Aging

Volumn 31, Issue 9, 2010, Pages 1637-1648

  Nogalska, Anna ^a   D'Agostino, Carla ^a   Engel, W King ^a   Davies, Kelvin J A ^b   Askanas, Valerie ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Acetylation; Aging; Cultured human muscle fibers; Endoplasmic reticulum stress; Histone H4; Human muscle; Neuromuscular junction; Nuclear factor B; SIRT1; Sporadic inclusion body myositis

Indexed keywords

AMYLOID BETA PROTEIN; HISTONE H4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN P53; SIRTUIN 1;

ADULT; AGED; AGING; ARTICLE; CALORIC RESTRICTION; CELL INCLUSION; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DEACETYLATION; ENZYME ACTIVITY; ENZYME DEFECT; HUMAN; HUMAN CELL; HUMAN TISSUE; LONGEVITY; MUSCLE CELL; MYOSITIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN TARGETING; TRANSCRIPTION INITIATION;

EID: 77954953341     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.08.021     Document Type: Article

References (54)

1. Abdelmohsen K., Pullmann R., Lal A., Kim H.H., Galban S., Yang X., Blethrow J.D., Walker M., Shubert J., Gillespie D.A., Furneaux H., Gorospe M. Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol. Cell 2007, 25:543-557.
2. Anastasiou D., Krek W. SIRT1: linking adaptive cellular responses to aging-associated changes in organismal physiology. Physiology 2006, 21:404-410.
3. Askanas V., Engel W.K. Cultured normal and genetically abnormal human muscle. The Handbook of Clinical Neurology, Myopathies 1992, vol. 18:85-116. North Holland, Amsterdam.
4. Askanas V., Engel W.K. Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease. J. Neuropathol. Exp. Neurol. 2001, 60:1-14.
5. Askanas V., Engel W.K. Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition. Neurology 2006, 66:S39-48.
6. Askanas V., Engel W.K. Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis. Curr. Opin. Rheumatol. 2007, 19:550-559.
7. Askanas V., Engel W.K., Alvarez R.B. Strong immunoreactivity of beta-amyloid precursor protein, including the beta-amyloid protein sequence, at human neuromuscular junctions. Neurosci. Lett. 1992, 143:96-100.
8. Askanas V., Alvarez R.B., Engel W.K. Beta-amyloid precursor epitopes in muscle fibers of inclusion body myositis. Ann. Neurol. 1993, 34:551-560.
9. Askanas V., Engel W.K., Alvarez R.B., McFerrin J., Broccolini A. Novel immunolocalization of alpha-synuclein in human muscle of inclusion-body myositis, regenerating and necrotic muscle fibers, and at neuromuscular junctions. J. Neuropathol. Exp. Neurol. 2000, 59:592-598.
10. Basak S., Kim H., Kearns J.D., Tergaonkar V., O'Dea E., Werner S.L., Benedict C.A., Ware C.F., Ghosh G., Verma I.M., Hoffmann A. A fourth IkappaB protein within the NF-kappaB signaling module. Cell 2007, 128:369-381.
11. Broccolini A., Ricci E., Pescatori M., Papacci M., Gliubizzi C., D'Amico A., Servidei S., Tonali P., Mirabella M. Insulin-like growth factor I in inclusion-body myositis and human muscle cultures. J. Neuropathol. Exp. Neurol. 2004, 63:650-659.
12. Broccolini A., Gidaro T., Morosetti R., Gliubizzi C., Servidei T., Pescatori M., Tonali P.A., Ricci E., Mirabella M. Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis. J. Neurochem. 2006, 96:777-789.
13. Chen J., Zhou Y., Mueller-Steiner S., Chen L.F., Kwon H., Yi S., Mucke L., Gan L. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J. Biol. Chem. 2005, 280:40364-40374.
14. Dalakas M.C. Inflammatory, immune, and viral aspects of inclusion-body myositis. Neurology 2006, 66:S33-38.
15. Engel W.K., Askanas V. Inclusion-body myositis: clinical, diagnostic, and pathologic aspects. Neurology 2006, 66:S20-29.
16. Fratta P., Engel W.K., McFerrin J., Davies K.J., Lin S.W., Askanas V. Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-{beta} precursor protein-overexpressing cultured human muscle fibers. Am. J. Pathol. 2005, 167:517-526.
17. Gan L., Mucke L. Paths of convergence: sirtuins in aging and neurodegeneration. Neuron 2008, 58:10-14.
18. Graham C., Tucker C., Creech J., Favours E., Billups C.A., Liu T., Fouladi M., Freeman B.B., Stewart C.F., Houghton P.J. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo. Clin. Cancer Res. 2006, 12:223-234.
19. Guarente L. Calorie restriction and SIR2 genes-towards a mechanism. Mech. Ageing Dev. 2005, 126:923-928.
20. Haigis M.C., Guarente L.P. Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev. 2006, 20:2913-2921.
21. Hasselgren P.O. Ubiquitination, phosphorylation, and acetylation-triple threat in muscle wasting. J. Cell. Physiol. 2007, 213:679-689.
22. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Scherer B., Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
23. Jin X., Lee J.S., Kwak S., Jung J.E., Kim T.K., Xu C., Hong Z., Li Z., Kim S.M., Whang K.Y., Hong K.C., You S., Choi Y.J., Kim H. Myogenic differentiation of p53- and Rb-deficient immortalized and transformed bovine fibroblasts in response to MyoD. Mol. Cell 2006, 21:206-212.
24. Joulia-Ekaza D., Cabello G. Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects. Exp. Cell Res. 2006, 312:2401-2414.
25. Kim D., Nguyen M.D., Dobbin M.M., Fischer A., Sananbenesi F., Rodgers J.T., Delalle I., Baur J.A., Sui G., Armour S.M., Puigserver P., Sinclair D.A., Tsai L.H. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 2007, 26:3169-3179.
26. Kim E.J., Kho J.H., Kang M.R., Um S.J. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol. Cell 2007, 28:277-290.
27. Kumamoto T., Ueyama H., Tsumura H., Toyoshima I., Tsuda T. Expression of lysosome-related proteins and genes in the skeletal muscles of inclusion body myositis. Acta Neuropathol. 2004, 107:59-65.
28. Lee I.H., Cao L., Mostoslavsky R., Lombard D.B., Liu J., Bruns N.E., Tsokos M., Alt F.W., Finkel T. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3374-3379.
29. Li Y., Schwabe R.F., DeVries-Seimon T., Yao P.M., Gerbod-Giannone M.C., Tall A.R., Davis R.J., Flavell R., Brenner D.A., Tabas I. Free cholesterol-loaded macrophages are an abundant source of Tumor Necrosis Factor-{alpha} and Interleukin-6: model of NF-{kappa}B- and MAP kinase-dependent inflammation in advanced atherosclerosis. J. Biol. Chem. 2005, 280:21763-21772.
30. Longo V.D., Kennedy B.K. Sirtuins in aging and age-related disease. Cell 2006, 126:257-268.
31. Marambaud P., Zhao H., Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J. Biol. Chem. 2005, 280:37377-37382.
32. Matsushita H., Scaglioni P.P., Bhaumik M., Rego E.M., Cai L.F., Majid S.M., Miyachi H., Kakizuka A., Miller W.H., Pandolfi P.P. In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR alpha blockade in the pathogenesis of acute promyelocytic leukemia. J. Exp. Med. 2006, 203:821-828.
33. Michan S., Sinclair D.A. Sirtuins in mammals: insights into their biological function. Biochem. J. 2007, 404:1-13.
34. Needham M., Mastaglia F.L. Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol. 2007, 6:620-631.
35. Nixon R.A. Autophagy, amyloidogenesis and Alzheimer disease. J. Cell Sci. 2007, 120:4081-4091.
36. Nogalska A., Wojcik S., Engel W.K., McFerrin J., Askanas V. Endoplasmic reticulum stress induces myostatin precursor protein and NF-kappaB in cultured human muscle fibers: relevance to inclusion body myositis. Exp. Neurol. 2007, 204:610-618.
37. Nogalska A., Engel W.K., McFerrin J., Kokame K., Komano H., Askanas V. Homocysteine-induced endoplasmic reticulum protein (Herp) is up-regulated in sporadic inclusion-body myositis and in endoplasmic reticulum stress-induced cultured human muscle fibers. J. Neurochem. 2006, 96:1491-1499.
38. Qin W., Yang T., Ho L., Zhao Z., Wang J., Chen L., Zhao W., Thiyagarajan M., MacGrogan D., Rodgers J.T., Puigserver P., Sadoshima J., Deng H., Pedrini S., Gandy S., Sauve A.A., Pasinetti G.M. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem. 2006, 281:21745-21754.
39. Salminen A., Ojala J., Huuskonen J., Kauppinen A., Suuronen T., Kaarniranta K. Interaction of aging-associated signaling cascades: inhibition of NF-kappaB signaling by longevity factors FoxOs and SIRT1. Cell. Mol. Life Sci. 2008, 65:1049-1058.
40. Sarkozi E., Askanas V., Johnson S.A., Engel W.K., Alvarez R.B. beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. Neuroreport 1993, 4:815-818.
41. +-dependent histone deacetylase SIRT1. J. Biol. Chem. 2007, 282:6823-6832.
42. Terracciano C., Nogalska A., Engel W.K., Wojcik S., Askanas V. In inclusion-body myositis muscle fibers Parkinson-associated DJ-1 is increased and oxidized. Free Radic. Biol. Med. 2008, 45:773-779. 10.1016/j.freeradbiomed.2008.05.030.
43. +-dependent deacetylation of H4 lysine 16 by class III HDACs. Oncogene 2007, 26:5505-5520.
44. Vaquero A., Scher M., Lee D., Erdjument-Bromage H., Tempst P., Reinberg D. Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol. Cell 2004, 16:93-105.
45. Vattemi G., Engel W.K., McFerrin J., Askanas V. Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. Am. J. Pathol. 2004, 164:1-7.
46. Vaziri H., Dessain S.K., Ng Eaton E., Imai S.I., Frye R.A., Pandita T.K., Guarente L., Weinberg R.A. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001, 107:149-159.
47. Wang J., Ho L., Zhao Z., Seror I., Humala N., Dickstein D.L., Thiyagarajan M., Percival S.S., Talcott S.T., Pasinetti G.M. Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. Faseb J. 2006, 20:2313-2320.
48. Wojcik S., Engel W.K., McFerrin J., Askanas V. Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers. Acta Neuropathol. 2005, 110:173-177.
49. Wojcik S., Nogalska A., McFerrin J., Engel W.K., Oledzka G., Askanas V. Myostatin precursor protein is increased and associates with amyloid-beta precursor protein in inclusion-body myositis culture model. Neuropathol. Appl. Neurobiol. 2007, 33:238-242.
50. Yamamoto H., Schoonjans K., Auwerx J. Sirtuin functions in health and disease. Mol. Endocrinol. 2007, 21:1745-1755.
51. Yang C.C., Alvarez R.B., Engel W.K., Askanas V. Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis. Neuroreport 1996, 8:153-158.
52. Yang C.C., Askanas V., Engel W.K., Alvarez R.B. Immunolocalization of transcription factor NF-kappaB in inclusion-body myositis muscle and at normal human neuromuscular junctions. Neurosci. Lett. 1998, 254:77-80.
53. Yang Y., Fu W., Chen J., Olashaw N., Zhang X., Nicosia S.V., Bhalla K., Bai W. SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nat. Cell Biol. 2007, 9:1253-1262.
54. Yeung F., Hoberg J.E., Ramsey C.S., Keller M.D., Jones D.R., Frye R.A., Mayo M.W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004, 23:2369-2380.